Publication at Third Faculty of Medicine |
2021
Abstract
Prostate cancer is the most common neoplasm in male population. Despite radical therapy in signifiant number of patients recurrence occures.
The recurrence is indicated by PSA level elevation. However for adequate treatment setup localisation of site of reccurece is essential.
Fluciclovine is radiotracer used for PET imaging. It is well accumulated in prostate cancer cells.
Therefore fluciclovine PET/CT stands for sensititive reccurence localisation method in patients suffering from prostate cancer. In this paper we summarize the use of fluciclovine PET/CT in recurrent prostate cancer patients.